Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc..
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Leslie Meltzer: trading record in brief
All filings by Leslie Meltzer on record concern Apellis Pharmaceuticals, Inc., in the capacity of senior executive. In total, 3 filings cover trades dated from 26 August 2025 to 14 May 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The latest filing, published on 14 May 2026, reports a transaction in Apellis Pharmaceuticals, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Leslie Meltzer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
107,024 sharesCommon StockSEC:0001193125-26-224620:0
45,220 shares0Common StockSEC:0001492422-26-000075:0
61,804 shares0Common StockSEC:0001127602-25-021056:0
3 of 3 declarations
